Spots Global Cancer Trial Database for cancer of the renal pelvis
Every month we try and update this database with for cancer of the renal pelvis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors | NCT01352962 | Urethral Neopla... Neoplasms, Uret... Cancer of the U... Urethral Cancer | Gemcitabine Carboplatin Lenalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors | NCT01352962 | Urethral Neopla... Neoplasms, Uret... Cancer of the U... Urethral Cancer | Gemcitabine Carboplatin Lenalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma | NCT01328574 | Urothelial Carc... Ureteral Neopla... Ureter Cancer Neoplasm, Urete... Cancer of the U... | TRC105 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) |